AC Immune SA (ACIU)
2.35
-0.03
(-1.26%)
USD |
NASDAQ |
Apr 19, 16:00
2.35
0.00 (0.00%)
After-Hours: 17:09
AC Immune Cash from Operations (TTM): -67.27M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -67.27M |
| September 30, 2023 | -69.06M |
| June 30, 2023 | -67.37M |
| March 31, 2023 | -70.22M |
| December 31, 2022 | -77.14M |
| September 30, 2022 | -77.89M |
| June 30, 2022 | -79.41M |
| March 31, 2022 | -77.76M |
| December 31, 2021 | -71.87M |
| September 30, 2021 | -71.95M |
| June 30, 2021 | -74.63M |
| March 31, 2021 | -72.64M |
| December 31, 2020 | -63.48M |
| September 30, 2020 | -57.06M |
| June 30, 2020 | -20.71M |
| March 31, 2020 | -20.65M |
| December 31, 2019 | 55.58M |
| Date | Value |
|---|---|
| September 30, 2019 | 56.77M |
| June 30, 2019 | 26.54M |
| March 31, 2019 | 35.24M |
| December 31, 2018 | -45.06M |
| September 30, 2018 | -25.72M |
| June 30, 2018 | -21.99M |
| March 31, 2018 | -24.67M |
| December 31, 2017 | -22.43M |
| September 30, 2017 | -36.59M |
| June 30, 2017 | -19.54M |
| March 31, 2017 | -9.829M |
| December 31, 2016 | -5.731M |
| September 30, 2016 | -4.354M |
| June 30, 2016 | 21.35M |
| March 31, 2016 | 16.65M |
| December 31, 2015 | 45.81M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-79.41M
Minimum
Jun 2022
56.77M
Maximum
Sep 2019
-47.38M
Average
-69.06M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
| Roche Holding AG | 18.04B |
| CRISPR Therapeutics AG | -260.38M |
| Addex Therapeutics Ltd | -11.74M |
| NLS Pharmaceutics Ltd | -13.51M |
| Molecular Partners AG | -65.71M |